Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5136802014 | Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5136803016 | Product containing precisely domperidone 30 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Is a | Domperidone and rabeprazole only product in oral dose form | true | Inferred relationship | Some | ||
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has manufactured dose form | Gastro-resistant and prolonged-release oral capsule (dose form) | true | Inferred relationship | Some | ||
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has precise active ingredient | Rabeprazole sodium (substance) | true | Inferred relationship | Some | 1 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has basis of strength substance (attribute) | Rabeprazole sodium (substance) | true | Inferred relationship | Some | 1 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has precise active ingredient | Domperidone (substance) | true | Inferred relationship | Some | 2 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has basis of strength substance (attribute) | Domperidone (substance) | true | Inferred relationship | Some | 2 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR